On The Fly: Pre-market Movers

HIGHER: PepsiCo (PEP), up 2% after reporting better than expected Q3 revenue and earnings, raising its FY16 core constant currency EPS growth guidance to up 10% from up 9%... Catabasis Pharmaceuticals (CATB), up 27% after announcing a joint research collaboration with Sarepta Therapeutics (SRPT) to explore a combination drug treatment approach for Duchenne muscular dystrophy... Aegerion (AEGR), up 35% after its JUXTAPID capsules were approved for HoFH treatment in Japan... Himax Technologies (HIMX), up 5% after reiterating its Q3 guidance and its business outlook for the remainder of 2016, "in light of the recent unusual volatility of the share price and the abnormally high trading volume" in its stock... eBay (EBAY), up 3% after Deutsche Bank upgraded the stock to Buy from Hold. UP AFTER EARNINGS: Pier 1 Imports (PIR), up 6.5%. LOWER: Intra-Cellular (ITCI), down 65% after neither dose of its schizophrenia drug separated from placebo on the primary endpoint in a Phase 3 clinical trial... Alcobra (ADHD), down 58% after announcing that it has received verbal notice from the Division of Psychiatry Products of the FDA that a full clinical hold has been placed on its Investigational New Drug, or IND, applications for MDX in ADHD and Fragile X Syndrome... Sonus Networks (SONS), down 8% following a downgrade to Underperform from Market Perform at Cowen... Fitbit (FIT), down 5% after Pacific Crest cut the stock to a sell-equivalent rating, citing channel checks indicating that the company's Charge 2 product is off to a slow start.